Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise
beta
Latest Financials
Filings:
By Category
By Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
Company Exhibits:
Indentures
Material Contracts & Credit Agreements
Plans of Reorganization
Articles and Bylaws
Underwriting Agreements
SEC Edgar
Ayr Wellness Inc.
SIC 2833 · Medicinal Chemicals & Botanical Products
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
Ayr Wellness Inc.
SIC 2833 · Medicinal Chemicals & Botanical Products
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
Ayr Wellness Inc.
SIC 2833 · Medicinal Chemicals & Botanical Products
Notes
Support
about
terms
Ayr Wellness Inc.
CIK:
0001847462
|
SEC Filings
Income Statement
Cash Flow
Balance Sheet
v3.25.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Consolidated Statements of Operations
Revenues, net of discounts
$ 463,633
$ 463,630
Cost of goods sold
286,952
261,188
Gross profit
176,681
202,442
Operating expenses
Selling, general, and administrative
167,134
177,800
Impairment of goodwill and other assets
118,113
6,320
Depreciation and amortization
48,061
51,364
Acquisition and transaction costs
4,358
4,080
Total operating expenses
337,666
239,564
Loss from continuing operations
(160,985)
(37,122)
Other income (expense), net
Fair value gain on financial liabilities, net
0
23,023
Loss on the extinguishment of debt
(79,172)
0
Loss on sale of assets
(3,665)
(91)
Interest expense, net
(78,258)
(39,403)
Interest income
323
743
Other income, net
2,671
7,094
Total other (expense) income, net
(158,101)
(8,634)
Loss from continuing operations before income taxes and noncontrolling interest
(319,086)
(45,756)
Income taxes
Current tax provision
(57,474)
(54,839)
Deferred tax benefit
14,200
7,448
Total income taxes
(43,274)
(47,391)
Net loss from continuing operations
(362,360)
(93,147)
Discontinued operations
Loss from discontinued operations, net of taxes (including loss on disposal of $182,464 for the year ended December 31, 2023)
0
(186,353)
Loss from discontinued operations
0
(186,353)
Net loss
(362,360)
(279,500)
Net loss attributable to noncontrolling interest
(3,051)
(7,067)
Net loss attributable to Ayr Wellness Inc.
$ (359,309)
$ (272,433)
Basic and diluted net loss per share
Continuing operations - basic
$ (3.24)
$ (1.16)
Continuing operations - diluted
(3.24)
(1.16)
Discontinued operations - basic
0
(2.52)
Discontinued operations - diluted
(2.52)
Basic net loss per share
(3.24)
(3.68)
Diluted net loss per share
$ (3.24)
$ (3.68)
Weighted average number of shares outstanding (basic)
110,832
74,096
Weighted average number of shares outstanding (diluted)
110,832
74,096
v3.25.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Operating activities
Consolidated net loss
$ (362,360)
$ (279,500)
Less: Loss from discontinued operations
0
(3,889)
Net loss from continuing operations before noncontrolling interest
(362,360)
(275,611)
Adjustments for:
Fair value gain on financial liabilities
0
(23,023)
Stock-based compensation
17,982
16,412
Shares issued for consulting services
0
79
Depreciation and amortization
28,230
32,303
Amortization of intangible assets
58,072
58,646
Amortization of financing costs
20,930
2,341
Amortization of financing discount
7,696
0
Amortization of financing premium
(53)
(3,018)
Provision for credit losses
1,006
0
Employee retention credits recorded in other income
(318)
(5,238)
Impairment of goodwill and other assets
118,113
6,320
Deferred tax (benefit) expense
(14,200)
(7,448)
Loss on sale of assets
3,665
91
Loss on the extinguishment of debt
79,172
0
Loss on the disposal of Arizona business
0
182,464
Changes in operating assets and liabilities:
Accounts receivable
(741)
(6,053)
Inventory
(6,763)
(6,252)
Prepaid expenses, deposits, and other current assets
5,424
(657)
Trade payables
4,703
(296)
Accrued liabilities
(6,617)
2,804
Accrued interest payable, current and non-current portions
(632)
(42)
Lease liabilities - operating
5,204
2,712
Income tax payable
(85,600)
47,848
Uncertain tax position liabilities
136,719
0
Cash provided by continuing operations
9,632
24,382
Cash provided by discontinued operations
0
2,783
Cash provided by operating activities
9,632
27,165
Investing activities
Purchase of property, plant, and equipment
(17,716)
(27,697)
Capitalized interest
(6,428)
(9,981)
Proceeds from the sale of assets
2,955
0
Cash paid for business combinations and asset acquisitions, net of cash acquired
0
(1,500)
Cash paid for business combinations and asset acquisitions, working capital
0
(2,600)
Cash paid for bridge financing
0
(73)
Purchase of intangible asset
(625)
(1,925)
Cash used in investing activities from continuing operations
(21,814)
(43,776)
Proceeds from sale of Arizona business - discontinued operation
0
18,084
Cash received for working capital - discontinued operations
0
1,583
Cash used in investing activities of discontinued operations
0
(44)
Cash used in investing activities
(21,814)
(24,153)
Financing activities
Proceeds from exercise of warrants
27
0
Proceeds from notes payable
40,000
10,665
Proceeds from financing transaction, net of financing costs
8,309
39,100
Debt issuance costs paid
(9,216)
(9,049)
Payment for settlement of contingent consideration
(10,094)
(10,475)
Tax withholding on stock-based compensation awards
(283)
(366)
Repayments of debts payable
(22,242)
(52,029)
Repayments of lease liabilities - finance (principal portion)
(9,603)
(10,608)
Cash used in financing activities by continuing operations
(3,102)
(32,762)
Cash used in financing activities from discontinued operations
0
(124)
Cash used in financing activities
(3,102)
(32,886)
Net decrease in cash and cash equivalents and restricted cash
(15,284)
(29,874)
Cash, cash equivalents and restricted cash at beginning of the period
50,766
76,827
Cash included in assets held-for-sale
0
3,813
Cash, cash equivalents and restricted cash at end of the period
35,482
50,766
Supplemental disclosure of cash flow information:
Interest paid during the period, net
58,252
49,914
Income taxes paid during the period, net
6,405
7,078
Non-cash investing and financing activities:
Recognition of right-of-use assets for operating leases
58,483
19,184
Recognition of right-of-use assets for finance leases
3,150
5,470
Issuance of promissory note related to business combinations
1,820
1,580
Conversion of convertible note related to business combination
700
2,800
Issuance of Equity Shares related to business combinations and asset acquisitions
210
115
Issuance of Equity Shares related to settlement of contingent consideration
0
4,647
Issuance of promissory note related to settlement of contingent consideration
0
14,000
Settlement of contingent consideration
0
38,420
Capital expenditure for cultivation facility
13,233
2,024
Extinguishment of construction finance liabilities for lease reclassification of cultivation facility
39,176
0
Extinguishment of note payable related to sale of Arizona business
0
22,505
Extinguishment of accrued interest payable related to sale of Arizona business
0
1,165
Reduction of lease liabilities related to sale of Arizona business
0
16,734
Reduction of right-of-use assets related to sale of Arizona business
0
16,739
Reclassification of right-of-use assets to property, plant, and equipment due to exercise of repurchase option at lease expiration
7,976
0
Retirement of Treasury Shares
8,987
0
Issuance of warrants in connection with debt extinguishment
47,049
0
Issuance of Equity Shares in connection with debt extinguishment
$ 94,302
$ 0
v3.25.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Current
Cash, cash equivalents and restricted cash
$ 35,482
$ 50,766
Accounts receivable, net
13,226
13,491
Inventory
112,558
106,093
Prepaid expenses, deposits, and other current assets
6,120
22,032
Asset held for sale
7,770
16,210
Total Current Assets
175,156
208,592
Non-current
Property, plant, and equipment, net
277,749
310,379
Intangible assets, net
616,661
673,745
Right-of-use assets - operating, net
164,260
126,131
Right-of-use assets - finance, net
27,644
40,671
Goodwill
0
94,108
Deposits and other assets
7,689
6,229
TOTAL ASSETS
1,269,159
1,459,855
Current
Trade payables
30,892
24,036
Accrued liabilities
27,022
40,836
Lease liabilities - operating - current portion
11,763
9,582
Lease liabilities - finance - current portion
5,385
9,789
Income tax payable
2,406
87,951
Debts payable - current portion
24,828
23,152
Accrued interest payable - current portion
1,249
1,983
Liabilities held for sale
5,774
3,850
Total Current Liabilities
109,319
201,179
Non-current
Deferred tax liabilities, net
50,763
64,965
Uncertain tax position liabilities
136,719
0
Lease liabilities - operating - non-current portion
179,602
125,038
Lease liabilities - finance - non-current portion
14,661
18,007
Construction finance liabilities
0
38,205
Long-term debts payable, net
385,646
411,306
Accrued interest payable - non-current portion
5,632
5,530
Other long- term liabilities
21,967
24,973
TOTAL LIABILITIES
904,309
889,203
Commitments and contingencies
Shareholders' equity
Additional paid-in capital
1,518,670
1,370,600
Treasury stock - nil and 645,300 shares, respectively
0
(8,987)
Accumulated other comprehensive income
3,266
3,266
Accumulated deficit
(1,142,410)
(783,101)
Equity of Ayr Wellness Inc.
379,526
581,778
Noncontrolling interest
(14,676)
(11,126)
TOTAL SHAREHOLDERS' EQUITY
364,850
570,652
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY
1,269,159
1,459,855
Multiple Voting Shares
Shareholders' equity
Shares
0
0
Subordinate, Restricted, and Limited Voting Shares
Shareholders' equity
Shares
0
0
Exchangeable Shares
Shareholders' equity
Shares
$ 0
$ 0